Stay updated on Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial

Sign up to get notified when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added to the history; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:16:21.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:36.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, replacing v3.4.1. A funding/operating-status notice was removed; these updates pertain to site-wide notices rather than the study record content.
    Difference
    0.5%
    Check dated 2026-02-11T02:57:00.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a government funding notice and a new Revision: v3.4.1. The previous Revision: v3.4.0 entry was removed.
    Difference
    0.5%
    Check dated 2026-02-04T01:15:29.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The history page now uses green and red highlights to indicate additions and deletions, and includes a glossary display option. The revision label has been updated to v3.4.0.
    Difference
    0.7%
    Check dated 2026-01-27T22:48:28.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Footer updates show Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed. The rest of the page content and study history remain unchanged.
    Difference
    0.1%
    Check dated 2025-12-23T02:34:43.000Z thumbnail image

Stay in the know with updates to Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.